Tralokinumab

ATC D11AH07 · 6 markets · 11 records

Tralokinumab 6 markets · 11 records Forms

US 2 records · 2 strengths

GB 2 records · 2 strengths

  • 300 mg/2 mLinjectionAdtralza 300mg/2ml solution for injection pre-filled pens also in US·FR
  • 150 mg/1 mLinjectionAdtralza 150mg/1ml solution for injection pre-filled syringes also in FR

CA 2 records · 2 strengths

ES 2 records · 2 strengths

FR 2 records · 2 strengths

  • 300 mg/2 mLinjectionADTRALZA 300 mg, solution injectable en stylo prérempli also in US·GB
  • 150 mg/1 mLinjectionADTRALZA 150 mg, solution injectable en seringue préremplie also in GB

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

    Side-by-side table

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.